Lawmakers Question FDA's Handling Of Actavis Recall
Two U.S. congressmen are raising questions about the U.S. Food and Drug Administration's oversight of drug facilities in the wake of a major recall by Actavis Totowa LLC earlier this year....To view the full article, register now.
Already a subscriber? Click here to view full article